Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Whil ...

Shares of Philip Morris (PM) have been strong performers lately, with the stock up 7% over the past month. The stock hit a new 52-week high of $165 in the previous session. Philip Morris has gained 35.6% since the start of the year compared to the 6.6% move for the Zacks Consumer Staples sector and the 26.7% return for the Zacks Tobacco industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of ...

Market Overview - The S&P 500 index is currently approximately 9% above its 52-week low recorded just last week, indicating a slight recovery in the market [1]. Investor Sentiment - There remains significant uncertainty in the financial markets, which could impact investor confidence and market stability [1].

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Imperial Tobacco Group PLC (IMBBY) - IMBBY currently holds a Momentum Style Score of B, indicating potential as a solid momentum pick [3][12] - The company has a Zacks Rank of 2 (Buy), which is associated with a strong track record of outperformance [4] Price Performance - Over the past week, IMBBY shares increased by 4.78%, outperforming the Zacks Tobacco industry, which rose by 2.48% [6] - In the last month, IMBBY's price change was 10.22%, significantly better than the industry's 1.55% [6] - Over the past quarter, IMBBY shares rose by 22.19%, and over the last year, they increased by 77.71%, while the S&P 500 saw declines of -10.88% and a modest increase of 5.91%, respectively [7] Trading Volume - IMBBY's average 20-day trading volume is 159,373 shares, which serves as a price-to-volume baseline; a rising stock with above-average volume is generally seen as bullish [8] Earnings Outlook - Recent earnings estimate revisions show positive trends, with one estimate moving higher for the full year, raising the consensus estimate from $4.09 to $4.13 over the past 60 days [10] - For the next fiscal year, one estimate has also moved upwards, with no downward revisions during the same period [10]

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving Altria Group, Inc. and its executives, following a downgrade by Deutsche Bank due to regulatory uncertainties impacting the company's e-vapor products [1][3]. Group 1: Investigation and Legal Actions - Pomerantz LLP is conducting an investigation on behalf of Altria investors regarding possible securities fraud or other unlawful business practices by the company and its officers [1]. - Investors are encouraged to contact Pomerantz LLP for more information about the investigation [1]. Group 2: Stock Performance and Analyst Ratings - On April 2, 2025, Deutsche Bank downgraded Altria's stock rating from "Buy" to "Hold" due to regulatory uncertainties after a ruling by the U.S. International Trade Commission regarding patent infringement related to Altria's NJOY ACE e-vapor products [3]. - Following the downgrade, Altria's stock price decreased by $1.67, or 2.84%, closing at $57.12 per share on the same day [3].

Core Viewpoint - The article emphasizes the importance of value investing and highlights Imperial Tobacco Group (IMBBY) as a strong value stock based on various financial metrics [2][7]. Group 1: Investment Metrics - IMBBY has a Zacks Rank of 2 (Buy) and a Value grade of A, indicating strong potential for value investors [4]. - The stock's Forward P/E ratio is 8.86, significantly lower than the industry average of 14.43, suggesting it may be undervalued [4]. - IMBBY's PEG ratio stands at 0.91, compared to the industry's average of 2.58, indicating favorable earnings growth expectations relative to its price [5]. - The P/B ratio for IMBBY is 4.21, which is attractive when compared to the industry's average P/B of 6.52 [6]. Group 2: Historical Performance - Over the past year, IMBBY's Forward P/E has fluctuated between 5.48 and 8.86, with a median of 6.89 [4]. - The PEG ratio for IMBBY has ranged from 0.73 to 1.03, with a median of 0.82 over the last 12 months [5]. - IMBBY's P/B ratio has varied between 2.90 and 4.21, with a median of 3.57 during the past year [6]. Group 3: Conclusion - The combination of these metrics suggests that Imperial Tobacco Group is likely undervalued, making it one of the strongest value stocks in the market [7].

Group 1: Company Performance - Imperial Tobacco Group PLC (IMBBY) has gained approximately 22.2% year-to-date, significantly outperforming the average return of 4.7% for the Consumer Staples sector [4] - The Zacks Consensus Estimate for IMBBY's full-year earnings has increased by 1% over the past three months, indicating improved analyst sentiment and a stronger earnings outlook [3] - In comparison to its industry, Imperial Tobacco Group PLC is slightly underperforming, as the Tobacco industry has seen an average gain of 24.7% this year [5] Group 2: Industry Context - The Consumer Staples sector, which includes 177 individual stocks, is currently ranked 8 in the Zacks Sector Rank [2] - The Tobacco industry, which includes Imperial Tobacco Group PLC, consists of 6 companies and is ranked 89 in the Zacks Industry Rank [5] - Nestle SA, another stock in the Consumer Staples sector, has outperformed the sector with a year-to-date return of 27.8% and has a Zacks Rank of 2 (Buy) [4][5]

Core Viewpoint - Philip Morris International Inc. is expected to show growth in both revenue and earnings for the first quarter of 2025, with revenue estimates around $9 billion, reflecting a 1.8% increase year-over-year [1]. Revenue and Earnings Estimates - The Zacks Consensus Estimate for quarterly earnings is $1.61 per share, indicating a 7.3% increase from the previous year [2]. - The company has a trailing four-quarter earnings surprise average of 4% [2]. Smoke-Free Product Performance - Smoke-free products contributed 40% to the company's net revenues in Q4 2024, showcasing the success of its IQOS device and other innovations like IQOS ILUMA, ZYN nicotine pouches, and VEEV ONE e-vapor [3]. - The estimated revenue from smoke-free products for Q1 2025 is $3,576.89 million, up from $3,296 million in the same quarter last year [4]. Cost Management and Strategic Initiatives - Philip Morris has implemented cost-saving measures and strategic initiatives that have positively impacted its margins [4]. Currency Impact and Regulatory Challenges - The company anticipates a 4-cent unfavorable impact on adjusted EPS due to volatile currency movements [5]. - Strict government regulations, including mandatory precautionary labels and self-critical advertisements, are challenges that may affect cigarette consumption [5]. Earnings Prediction Model - The current model does not predict a definitive earnings beat for Philip Morris, with a Zacks Rank of 3 and an Earnings ESP of -1.83% [6].

In its upcoming report, Philip Morris (PM) is predicted by Wall Street analysts to post quarterly earnings of $1.61 per share, reflecting an increase of 7.3% compared to the same period last year. Revenues are forecasted to be $8.95 billion, representing a year-over-year increase of 1.8%.The consensus EPS estimate for the quarter has undergone an upward revision of 2.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial ...

Core Insights - The Zacks Tobacco industry is transitioning towards smoke-free alternatives due to increasing consumer health awareness and stricter regulations on traditional cigarettes [1][5][6] - Major companies like Philip Morris International, Altria Group, and Turning Point Brands are heavily investing in reduced-risk products (RRPs) to leverage this trend [1][6] Industry Overview - The Zacks Tobacco industry encompasses companies that manufacture and sell cigarettes, cigars, snuffs, and nicotine-based products, including RRPs like e-cigarettes and vaping products [3] - Products in this industry are regulated by the U.S. Food and Drug Administration, which enforces permissible nicotine levels [4] Trends Impacting the Industry - There is a rising demand for smoke-free options driven by health concerns and government regulations aimed at reducing cigarette consumption [5] - Tobacco companies are focusing on innovations to enhance user experience and energy efficiency in RRPs, leading to significant revenue growth [6] Pricing Power and Sales Challenges - Tobacco companies maintain strong pricing power, allowing them to implement price increases despite declining cigarette sales volumes [7] - The industry faces challenges from inflation and regulatory restrictions, which are impacting cigarette sales and consumer behavior [8][9] Industry Performance - The Zacks Tobacco industry has outperformed the broader market, gaining 61.1% over the past year compared to the S&P 500's growth of 6.2% [13] - The industry is currently trading at a forward P/E of 14.37X, lower than the S&P 500's 19.88X [14] Company Highlights - **Philip Morris International**: Transitioning to a smoke-free future with a focus on RRPs like IQOS and ZYN, aiming for a majority smoke-free business by 2030. The Zacks Consensus Estimate for its EPS is $7.18, with shares gaining 76.7% in the past year [15][17][16] - **Altria Group**: Focusing on smoke-free brands like NJOY and on!, while modernizing operations through its "Optimize and Accelerate" initiative. The Zacks Consensus Estimate for its EPS is $5.31, with shares increasing by 40% in the past year [18][19] - **Turning Point Brands**: Experiencing growth through its core brands and modern oral nicotine products, with a Zacks Consensus Estimate for its EPS at $3.42 and shares soaring 115.8% in the past year [20][22]